Best Medical Stocks For 2018


The inks barely dry on a cannabis deal of epic proportions.

Three of the worlds leading marijuana companies have decided to pool their resources in a huge joint venture.

The deal struck between Canadas Canopy Growth, Hollands Green House Brands and the U.S. own Organa Brands marks the first time in history a legal weed cartel will exist.

Amazing how times can change so quickly, isnt it?

Under this new joint venture, Canopy Growth will give minority ownership stakes in its medical marijuana subsidiary, Agripharm, to Amsterdams Green House Brands and Denver-based Organa Brands.

In exchange for the stakes in Agripharm, Green House and Organa Brands will each give Canopy exclusive royalty-free rights to their trademarks, genetics and other intellectual properties.

The venture will kick off in Canada first, as thats where the Agripharm subsidiary is based. But expansion into the U.S. and Holland will follow shortly.


Commenting on the partnership, Chris Driessen, president and owner of Organa Brands, had this to say: The sky’s the limit when you have three of the most influential cannabis brands in the world unifying to start the process of global expansion.

Best Medical Stocks For 2018: Coca-Cola Company (The)(KO)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Some money managers are indeed preparing for Armageddon, expecting a thin summer trading season to usher in the bear. But Cramer said that, ultimately, what happens in Washington has little impact on the earnings of stocks like Walmart (WMT) , Coca-Cola (KO) or Citigroup (C) . It also has no correlation to the 17.8% move in Nvidia (NVDA) , nor the 12.8% jump in Electronic Arts (EA) .

  • [By WWW.THESTREET.COM]


    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Javier Hasse]

    “I can see Isodiol being the dominant company in the CBD space, not only in the U.S., but in the whole world,” Washington said, pointing out that he believes the firm will soon be able to compete with early-entrant GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), even becoming the The Coca-Cola Co (NYSE: KO) or PepsiCo, Inc. (NYSE: PEP) of cannabis therapeutics.

Best Medical Stocks For 2018: Endocyte, Inc.(ECYT)


Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

  • [By Benzinga News Desk]

    Carl Icahn has big plans for the US auto-parts sector — and big retailers like AutoZone (NYSE: AZO), O’Reilly Automotive (NASDAQ: ORLY) and Advance Auto Parts (NYSE: AAP) aren’t going to like them: Link


    ECONOMIC DATA
    USA Unit Labor Costs (QoQ) for Q1 2.20% vs 2.50% consensus estimate. Nonfarm Productivity (QoQ) for Q1 0.00% vs -0.20% consensus estimate.
    US Services Purchasing Managers' Index for May is schedule for release at 9:45 a.m. ET.
    Data on factory orders for April will be released at 10:00 a.m. ET.
    The ISM non-manufacturing index for May is schedule for release at 10:00 a.m. ET.
    The labor market conditions index for May will be released at 10:00 a.m. ET.
    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.
    The TD Ameritrade Investor Movement Index for May is schedule for release at 12:30 p.m. ET.
    ANALYST RATINGS
    HSBC upgraded Chevron (NYSE: CVX) from Hold to Buy
    Susquehanna upgraded Skechers (NYSE: SKX) from Neutral to Positive
    Deutsche Bank upgraded WEX (NYSE: WEX) from Hold to Buy
    Pacific Crest downgraded Apple from Overweight to Sector Weight
    RBC downgraded Perrigo (NYSE: PRGO) from Sector Perform to Underperform
    Wedbush downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral


    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

Best Medical Stocks For 2018: Carter's, Inc.(CRI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

Best Medical Stocks For 2018: Newcastle Investment Corporation(NCT)


Advisors’ Opinion:

  • [By Lee Jackson]

    Newcastle Investment Corp. (NYSE: NCT) also had a director buying shares this past week. Wesley Edens picked up1 million shares of the stock at a price of $4.37. The total for the trade was posted at $4,370,000. The consensus price target for the stock is $4.50.The company invests in and manages real estate related and other investments. Its stock ended the weekat $4.31.

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested shortingsmall cap debt and golf course REITNewcastle Investment Corp (NYSE: NCT):


    this isn’t apt to become a huge winner, but it’s a high-odds winner.

Best Medical Stocks For 2018: Allegheny Technologies Incorporated(ATI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Leave a Reply

Your email address will not be published.